Principle component analysis as applied to volume effects in treatment outcomes for patients with prostate cancer treated with 3D-CRT

被引：0
|
作者：
Bauer, J [1 ]
Jackson, A [1 ]
Skwarchuk, M [1 ]
Zelefsky, M [1 ]
Leibel, S [1 ]
Ling, C [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MEDICAL PHYSICS | 2004年 / 31卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1910 / 1910
页数：1
相关论文
共 50 条
  • [1] Principal component, Varimax rotation and cost analysis of volume effects in rectal bleeding in patients treated with 3D-CRT for prostate cancer
    Bauer, J. D.
    Jackson, Andrew
    Skwarchuk, Mark
    Zelefsky, Michael
    PHYSICS IN MEDICINE AND BIOLOGY, 2006, 51 (20): : 5105 - 5123
  • [2] Toxicity analysis of breast cancer patients treated with VMAT and 3D-CRT
    Seppala, J.
    Vuorinen, K.
    Miettinen, N.
    Heikkila, J.
    Tengstrom, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1003 - S1005
  • [3] IMRT versus 3D-CRT in the treatment of prostate cancer: comparison of outcomes and toxicity.
    Guo, W.
    Sun, Y. C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S614 - S614
  • [4] Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer
    Bruner, DW
    Hanlon, A
    Mazzoni, S
    Raysor, S
    Konski, A
    Hanks, G
    Pollack, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01): : 34 - 42
  • [5] Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer
    Someya, Masanori
    Hori, Masakazu
    Tateoka, Kunihiko
    Nakata, Kensei
    Takagi, Masaru
    Saito, Masato
    Hirokawa, Naoki
    Hareyama, Masato
    Sakata, Koh-ichi
    JOURNAL OF RADIATION RESEARCH, 2015, 56 (01) : 122 - 127
  • [6] Quality of life outcomes in patients with Head & Neck Cancer treated with IMRT compared to 3D-CRT
    Debojoyti, D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S23 - S24
  • [7] Is adjuvant hormonal therapy necessary to Japanese patients with locally advanced prostate cancer treated by 3D-CRT?
    Sakamoto, M.
    Mizowaki, T.
    Mitsumori, M.
    Takayama, K.
    Sasai, K.
    Negoro, Y.
    Norihisa, Y.
    Kamoto, T.
    Ogawa, O.
    Hiraoka, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S339 - S339
  • [8] Efficacy of a hydrogel spacer in 3D-CRT for prostate cancer
    Ogita, M.
    Yamashita, H.
    Sawayanagi, S.
    Takahashi, W.
    Nakagawa, K.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1024 - S1025
  • [9] Cetuximab, Capecitabine,3D-CRT vs capecitabine,3D-CRT as preoperative treatment in rectal cancer
    Mavroeidi, P.
    Varveris, A.
    Spanakis, A.
    Varveris, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S796 - S797
  • [10] CT and MRI in 3D-CRT planning of prostate cancer
    Vanuytsel, L
    Gatti, GM
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S39 - S39
12345